NCT03664440View on ClinicalTrials.gov

Efficacy of Rilpivirine-based Regimens as Switch Therapy From Nevirapine-based Regimens in HIV-infected Patients

NACompletedINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

December 1, 2016

Primary Completion Date

October 31, 2017

Study Completion Date

October 31, 2017

Conditions
Efficacy of Rilpivirine-based Regimens as Switch Therapy
Interventions
DRUG

Nevirapine

Patients were randomized 1:1 to continuation arm (NVP-based regimens). Tenofovir disoproxil fumarate (TDF) plus lamivudine (3TC) or emtricitabine (FTC) remained as the backbone of the regimens.

DRUG

Rilpivirine

Patients were randomized 1:1 to switch arm (NVP-based regimens were switched to RPV-based regimens). Tenofovir disoproxil fumarate (TDF) plus lamivudine (3TC) or emtricitabine (FTC) remained as the backbone of the regimens.

Trial Locations (1)

Unknown

Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok

All Listed Sponsors
lead

Mahidol University

OTHER

NCT03664440 - Efficacy of Rilpivirine-based Regimens as Switch Therapy From Nevirapine-based Regimens in HIV-infected Patients | Biotech Hunter | Biotech Hunter